Guidelines for the management of hypertension in CKD patients: where do we stand in 2024?
Overview
Paper Summary
This review summarizes the 2023 European Society of Hypertension (ESH) guidelines for managing high blood pressure in patients with chronic kidney disease (CKD), highlighting key updates and comparing them with the 2021 KDIGO guidelines. The ESH guidelines offer detailed algorithms for antihypertensive agent selection and address treatment of resistant hypertension in CKD, emphasizing a holistic approach to cardioprotection and nephroprotection.
Explain Like I'm Five
New guidelines help doctors treat high blood pressure in people with kidney problems, focusing on protecting their heart and kidneys. They recommend certain medications and lifestyle changes tailored to the patient's kidney health.
Possible Conflicts of Interest
Alberto Ortiz is a former Editor-in-Chief of the Clinical Kidney Journal, and Mehmet Kanbay is a member of the journal's Editorial Board. The supplement containing this review was financially supported by the ERA.
Identified Limitations
Rating Explanation
This is a strong review that provides valuable clinical guidance for managing hypertension in CKD patients. It synthesizes the latest evidence and offers practical algorithms for treatment. While the lack of direct comparison trials and the extrapolation of evidence from other populations are limitations, the guidelines offer a helpful framework for clinical practice.
Good to know
This is the Starter analysis. Paperzilla Pro fact-checks every citation, researches author backgrounds and funding sources, and uses advanced AI reasoning for more thorough insights.
Explore Pro →